-
Contextual Genomics launches new liquid biopsy test and updated solid tumor panel
fiercebiotech
January 04, 2019
Vancouver-based Contextual Genomics has launched two molecular hotspot assays for detecting genomic mutations in blood and solid tumors.....
-
Super-resolution microscopy to identify molecular interactions
europeanpharmaceuticalreview
August 22, 2018
The researchers used a technique called DNA-PAINT, which utilises fluorescent markers to tag DNA and identify various molecules within a cell…
-
Molecular Partners names Regeneron cancer leader as CSO in reshuffle of leadership team
fiercebiotech
June 25, 2018
Molecular Partners has rejigged its leadership team, hiring Pamela Trail, Ph.D., from Regeneron to serve as CSO and shunting Michael Stumpp, Ph.D., across to the COO position.
-
Scientists discover a small molecule that halts kidney disease progression
europeanpharmaceuticalreview
December 11, 2017
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
-
Boehringer Ingelheim makes its best molecules available to the scientific community
europeanpharmaceuticalreview
November 22, 2017
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide…
-
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.
biospectrumasia
June 07, 2017
This panel along with the BD MAX enteric bacterial panel and the BD MAX enteric parasite panel, aims to enable individualized testing that can be be performed based on a patient's symptoms and health history.
-
U.S. Molecular Imaging Companies Leverage Technology Innovation And Design Modularity to Widen The M
en-cphi.cn
May 03, 2017
Novel PET and SPECT radiopharmaceuticals will drive growth opportunities in broader clinical segments, finds Frost & Sullivan's Transformational Health team
-
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle fo
b3cnewswire
April 12, 2017
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay
-
Angsana’s RNA-based fusions cancer panel selected for Ignyta’s STARTRK2 clinical trial in Asia-Pacif
pharmaasia
March 16, 2017
Angsana Molecular & Diagnostics to partner with molecular test laboratory for STARTRK-2 clinical trial sites in Asia working with Ignyta.